Comorbidity in predicting surgical outcomes for gastric cancer

Objective: The present study aimed to analyze the treatment outcomes and develop a predictive model of surgical treatment for gastric cancer, taking into account the comorbidity of patients.
Material and Methods. The treatment outcomes were studied in 477 (100 %) gastric cancer patients. Patients were stratifed into two groups according to the Age-Adjusted Charlson Comorbidity Index (ACCI) (0–4 points – 311 (65,2 %), more than 4 points – 166 (34,8 %) patients). Two hundred and seventy six patients (57.9 %) underwent distal or total gastrectomy, 178 (37.3 %) total gastrectomy, 19 (4 %) minimally invasive gastrectomy, and 4 (0.8 %) patients underwent extirpation of the gastric stump. The construction of models for the prognosis of surgical treatment was carried out using binary logistic regression, the comparison of models – by analyzing error curves (ROC-analysis).
Results. The incidence rate of postoperative complications (grade III-V) according to the Clavien-Dindo classifcation was signifcantly higher in group 2 (9.9 %, 47/477) compared to group 1 (2.1 %, 10/477) (χ2 =64.79, p<0.001; OR 11.9 [5.82–24.3]). Postoperative mortality rate was 0.2 % (1/477) in group 1 and 1.9 % (9/477) in group 2 (χ2 =13.7, p<0.001; OR 17.8 [2.23–142]). In a comparative analysis, the prognostic model, taking into account the ACCI of the patient, allowed prediction of the development of postoperative grade III–V complications according to the Clavien-Dindo with the greatest accuracy. The area under the curve (AUC) was 0.921 ± 0.01 (95 % CI: 0,96–0,998), sensitivity – 71.9 %, specifcity – 99.8 %, diagnostic accuracy – 96.4 %.
Conclusion. The inclusion of comorbidity in gastric cancer patients in the predictive concept makes it possible to improve the accuracy of prediction of postoperative complications of III–V grade according to Clavien-Dindo.

1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3): 209–49. doi: 10.3322/caac.21660.

2. Pavlov R.V., Timofeeva K.O., Chernykh M.A., Danilin V.N. Safety and benefts of early oral nutrition as part of the fast-track program among patients who have undergone gastrectomy for stomach cancer. Siberian Journal of Oncology. 2022; 21(2): 81–7. (in Russian). doi: 10.21294/1814-4861-2022-21-2-81-87.

3. Malignant tumors in Russia in 2020 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow, 2021. 239 p. (in Russian).

4. Besova N.S., Kalinin A.E., Nered S.N., Tryakin A.A., Gamaynov S.V. Clinical guidelines «Gastric cancer». 2020. 95 p. (in Russian).

5. Izrailov R.E., Pomortsev B.A., Khatkov I.E., Karachun A.M., Pelipas Yu.V., Sapronov P.A., Ryabov A.B., Khomyakov V.M., Kolobaev I.V., Kanner D.Yu., Kononec P.V., Kashchenko V.A., Vasyukova E., Gluzman M., Lando M.N., Shinkarev S.A., Brikin V.N., Zheveliuk A.G., Popov A.Yu., Zhuravlev P.A., Popov A.Yu., Petrovsky A.N., Boydo S.V., Golub D.A., Neymark A.E., Danilov I.N., Maslev V.V. Effectiveness of laparoscopic gastrectomy in patients with locally advanced gastric cancer: a prospective, multicenter study. Endoscopic surgery. 2019; 25(5): 10–7. (in Russian). doi: 10.17116/endoskop20192505110.

6. Maezawa Y., Aoyama T., Kano K., Tamagawa H., Numata M., Hara K., Murakawa M., Yamada T., Ogata T., Oshima T., Yukawa N., Yoshikawa T., Masuda M., Rino Y. Impact of the Age-adjusted Charlson comorbidity index on the short- And long-term outcomes of patients undergoing curative gastrectomy for gastric cancer. J Cancer. 2019; 10(22): 5527–35. doi: 10.7150/jca.35465.

7. Allakhverdyan A.S., Anipchenko A.N., Anipchenko N.N., Tulskikh D.A. Immediate results of laparoscopic partial and total gastrectomies in cancer. Modern Science: Current Problems of Theory and Practice. 2021; (7): 153–6. (in Russian). doi: 10.37882/2223–2966.2021.07.03.

8. Akhmetzyanov F.Sh., Kaulgud H.A., Akhmetzyanova F.F. Surgical outcomes in patients with proximal gastric cancer without esophageal invasion. Siberian Journal of Oncology. 2021; 20(4): 84–90. (in Russian). doi: 10.21294/1814-4861-2021-20-4-84-90.

9. Wang S., Xu L., Wang Q., Li J., Bai B., Li Z., Wu X., Yu P., Li X., Yin J. Postoperative complications and prognosis after radical gastrectomy for gastric cancer: a systematic review and meta-analysis of observational studies. World J Surg Oncol. 2019; 17(1): 1–10. doi:10.1186/S12957-019-1593-9.

10. Chen G., Wang J., Chen K., Kang M., Zhang H., Jin X., Lin L., Chen J. Relationship between postoperative complications and the prognosis of gastric carcinoma patients who underwent surgical resection: a systematic review and meta-analysis. Cancer Control. 2021; 28: 1–12. doi: 10.1177/10732748211011955.

11. Xu Y., Wang Y., Xi C., Ye N., Xu X. Is it safe to perform gastrectomy in gastric cancer patients aged 80 or older? Medicine. 2019; 98(24): 10–6. doi:10.1097/MD.0000000000016092.

12. Mita K., Ito H., Katsube T., Tsuboi A., Yamazaki N., Asakawa H., Hayashi T., Fujino K. Prognostic factors afecting survival after multivisceral resection in patients with clinical T4b gastric cancer. J Gastrointest Surg. 2017; 21(12): 1993–9. doi: 10.1007/S11605-017-3559-Y.

13. Dindo D., Demartines N., Clavien P.A. Classifcation of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240(2): 205–13. doi: 10.1097/01.sla.0000133083.54934.ae.

14. Stilidi I.S., Merzlyakov V.Yu., Skopin A.I., Baychurin R.K., Vashakmadze L.A., Kalinin O.Ye., Salimova A.A. Simultaneous coronary artery bypass and total gastrectomy. Clinical and Experimental Surgery. Petrovsky Journal. 2021; 9(1): 81–3. (in Russian). doi: 10.33029/2308-1198-2021-9-1-81-83.

15. Tian Y., Jian Z., Xu B., Liu H. Age-adjusted Charlson comorbidity index score as predictor of survival of patients with digestive system cancer who have undergone surgical resection. Oncotarget. 2017; 8(45): 79453–61. doi: 10.18632/oncotarget.18401.

16. Komarov R.N., Novikov S.S., Osminin S.V., Bilyalov I.R., Ryabov K.Y., Zavaruev A.V., Baziyants L.R., Astaeva M.O. Surgery for gastric cancer in patients with coronary heart disease (clinical cases). Russian Journal of Oncology. 2021; 26(6): 213–24. (in Russian). doi: 10.17816/onco111771.

17. Udalov Yu.D., Gordienko A.V., Samoilov A.S., Bakharev S.A. Forecasting and risks minimization of fatal adverse outcomes of elective surgical treatment of oncological patients with comorbid somatic pathology. Medicine of Extreme Situations. 2018; 20(2): 136–45. (in Russian).

18. Lin J.X., Huang Y.Q., Xie J.W., Wang J., Lu J., Chen Q.Y., Cao L., Lin M., Tu R.H., Huang Z.N., Lin J.L., Li P., Huang C.M., Zheng C.H. Age-adjusted Charlson Comorbidity Index (ACCI) is a signifcant factor for predicting survival after radical gastrectomy in patients with gastric cancer. BMC Surg. 2019; 19(1): 53. doi: 10.1186/s12893-019-0513-9.

19.